by Jayla Burton, Program Officer
Since our founding, Breast Cancer Action has worked to expand access to quality, evidence-based healthcare for all people. High drug prices and gaps in coverage for essential medical equipment prevent too many people from getting the treatment they need. Now there’s a bill before Congress that can help change that.
During the State of the Union, President Trump stated that he would sign a bill to reduce prescription drug costs – despite the Senate currently being unwilling to move H.R. 3 forward. House Democrats took action by standing up, raising three fingers in the air, and chanting “H-R-3” in response.
The Lower Drug Costs Now Act will:
• Provide Medicare coverage for medically necessary supplies to treat lymphedema, a painful and disabling condition that results from breast cancer treatment.
• Help lower costs and increase access to prescription drugs by allowing the government to negotiate drug prices and cap patients’ out-of-pocket spending on prescription drugs.
The House has already voted on and passed The Lower Drug Costs Now Act, which includes important provisions from the Lymphedema Treatment Act. Now it’s the Senate’s turn.